Trials / Conditions / Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

10 registered clinical trials studyying Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous NCT06580054	University of Michigan Rogel Cancer Center	Phase 2
Withdrawn	Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carbopl NCT06084845	ECOG-ACRIN Cancer Research Group	Phase 2
Withdrawn	Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung NCT05412875	Ohio State University Comprehensive Cancer Center	N/A
Active Not Recruiting	Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Tr NCT04576091	National Cancer Institute (NCI)	Phase 1
Terminated	Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With NCT05110781	Arnaud Bewley, MD	Phase 2
Completed	Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer NCT04870840	M.D. Anderson Cancer Center	Phase 1
Completed	Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies NCT03590054	Rahul Aggarwal	Phase 1
Active Not Recruiting	Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cel NCT03565783	M.D. Anderson Cancer Center	Phase 2
Completed	Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participant NCT03574792	Roswell Park Cancer Institute	Phase 2
Active Not Recruiting	CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or NCT02955290	Roswell Park Cancer Institute	Phase 1 / Phase 2